Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Senti Biosciences ( (SNTI) ) has shared an update.
On January 31, 2025, the Consulting Agreement between Senti Biosciences, Inc. and Yvonne Li, the Interim Chief Financial Officer, expired. Subsequently, Ms. Li ceased to serve as the company’s principal financial and accounting officer. However, on February 5, 2025, a new consulting agreement was established, allowing Ms. Li to continue as a consultant to assist with the transition of her duties until March 31, 2025.
More about Senti Biosciences
YTD Price Performance: 17.06%
Average Trading Volume: 2,423,966
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $21.54M
For an in-depth examination of SNTI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue